Trial design
This was a single-centre randomised controlled trial (RCT) of split-mouth design and blind assessment. Each patient received two identical implants (one test and one control implant): test implants were placed after having prepared the site with a piezoelectric device while control implants were placed in sites prepared with conventional drills.
Patient Selection
Any patient requiring at least two single implant-supported crowns in molar or premolar areas (wisdom teeth excluded), being at least 18 years old and able to understand and sign an informed consent form was eligible for inclusion. The two implant sites could be adjacent and had to allow the placement of two implants 11 mm long and 4.0 mm wide i.e. they had to have a bone height of at least 12 mm and a width of at least 7 mm. For patients with more than two suitable implant sites, the operator chose those two sites with more similar characteristics at the screening visit. The operator coded the selected sites as implant site number 1 and implant site number 2.
Exclusion criteria were:
- general contraindications to implant surgery;
- systemic diseases;
- immunosuppressed or immunocompromised patients;
- irradiation in the head and/or neck area;
- pregnancy or lactating;
- smokers;
- untreated periodontitis;
- poor oral hygiene and motivation (full-mouth plaque and bleeding scores less or equal to15%);
- substance abusers;
- psychiatric disorders;
- acute infection or suppuration at any of the sites intended for implant placement;
- need of any type of bone augmentation at implant placement;
- post-extractive sites (implants can be inserted after a healing of at least 6 months);
- unable to commit to 5-year follow-up;
- under treatment or had previous treatment with intravenous amino-bisphosphonates;
- patients referred only for implant placement if the follow-up cannot be done at the treatment centre;
- participation to other clinical studies if the present protocol could not be fully adhered to.
The study protocol was approved by the University of Mainz Ethics Committee (Ethics Committee No.: 837.1 85.1 5 (9953). Patients were recruited and treated by AA at the Department of Operative Dentistry and Periodontology of the University Medical Center (Mainz, Germany) using similar and standardised procedures. Prior to enrolment, all patients were asked to read, and once understood, to sign an informed consent formto document that they understood the scope of the study (including procedures, follow-up evaluations, and any potential risks involved), were allowed opportunities to ask questions pertaining to this study, and were apprised of treatment alternatives. All procedures were performed in accordance with the principles outlined in the Declaration of Helsinki. The study was open to any qualifying patients without regard to sex or race.
Clinical procedures
Preoperative panoramic radiographs were taken. Patients received a single dose of prophylactic antibiotic 1 hour prior to the intervention: 1 g of amoxicillin or 600 mg of clindamycin, if allergic to penicillin. Patients rinsed with chlorhexidine mouthwash 0.2% for 1 minute prior to the intervention. Patients were treated under local anaesthesia using articaine with adrenaline 1:100.000. After crestal incision, flap elevation was performed first vestibulary, and the thickness of the supracrestal mucosa was measured with a periodontal probe at the incision site (Fig 1). Thereafter the lingual/palatal flap was raised. The sequentially numbered sealed envelope corresponding to the patient recruitment number was opened and implant site number 1 was treated according to the content of the envelope. Consequently, implant site number 2 was treated with the other procedure, according to a split-mouth design. The two study implants were placed in the same surgical session following similar procedures and were restored simultaneously with similar single crowns.
Implant sites, randomly allocated to piezo instrumentation, were prepared using piezo-electric device (PIEZOSURGERY touch, Mectron, Cherasco, Italy), starting with a special tip for the initial preparation (IM1S Mectron) followed by IM2, IM3, IM3-4, P3-4 tipsby Mectron; Fig 2). Control sites per prepared using a sequence of conventional drills (Fig 3) as described by the manufacturer (VECTODrill Thommen Medical, Grenchen, Switzerland). Cylindrical SPI Element INICELL (Thommen) titanium grade 4 implants with a polished collar of 1 mm height and internal flat to flat hexagon connection were used (Fig 4). All implants were 11 mm long by 4 mm in diameter. Implants were placed by setting the motor with a torque of 30 Ncm. The neck of the implant was placed flush to the surrounding bone. At this point implant stability was measured by a blinded assessor (E.S.) using the Osstell Mentor RFA device (Osstell, Integration Diagnostics, Goteborg, Sweden) using the dedicated transducers (SmartPeg, Osstell) for the SPI 4.0 mm connection. All implants were measured twice (from mesio-distal and bucco-lingual directions). Finally, healing abutments were connected and flaps were sutured with 6.0 sutures (Premilene B/Braun Aesculap, Tuttlingen, Germany) around the abutments. Baseline periapical radiographs were taken (Fig 5a-d) and if the peri-implant marginal bone levels were difficult to be evaluated another periapical radiograph was taken. Ibuprofen 600 mg was prescribed to be taken thrice a day during meals, for 3 days. In case of stomach problems or allergy to non-steroidal anti-inflammatory drugs, 1g of paracetamol was recommended instead. Patients were instructed to use 0.12% chlorhexidine mouthwash for one minute thrice a day for 1 week, and to avoid brushing and possible trauma on the surgical sites. After 1 week, patients were checked, sutures were removed and oral hygiene instructions were delivered.
Implants were left to heal unloaded for 6 months (Fig 6a), and six months after surgery, implant level digital impressions were taken, screw-retained metal-ceramic crowns were fabricated on customised titanium abutments and delivered within 2 weeks (Fig 6b and c). Periapical radiographs were taken (Fig 6d), and oral hygiene instructions were delivered. Exactly the same procedures were implemented at both implants during the same sessions. Patients were recalled for maintenance every 3 months for the entire duration of the study.
Outcome measures
This study tested the null hypothesis that there were no differences in clinical outcome between the two procedures against the alternative hypothesis of a difference.
Outcome measures were:
- Implant/crown failures: implant mobility, removal of stable implants dictated by progressive marginal bone loss or infection, and any mechanical complications rendering the implant not usable (e.g. implant fracture) were considered implant failures. If a definitive crown had to be replaced for any reason, it accounted as a crown failure. The stability of individual implants was assessed clinically by attempting to rock the crown with the metal handles of two dental instruments at each follow-up visit.
- Any biological or biomechanical complications. Examples of biological complications are fistula and peri-implantitis. Examples of biomechanical complications are loosening or fracture of the abutment screw.
- Peri-implant marginal bone level changes evaluated on digital periapical radiographs taken with the paralleling technique at implant placement, 1 (Fig. 5d), 3, 6 (Fig. 6d), 12, 24 months and at 5 years (Fig. 7a-c) after initial implant placement. In case of an unreadable radiograph, a second radiograph was obtained. Peri-implant marginal bone levels were measured using the Planmeca software (Helsinki, Finland). The software was calibrated for every single image using the known implant diameter. Measurements of the mesial and distal bone crest level adjacent to each implant were made to the nearest 0.01 mm. Reference points for the linear measurements were the coronal margin of the implant collar and the most coronal point of visible bone-to-implant contact. The measurements at mesial and distal sides of each implants were averaged at implant level and then at group level.
- Resonance frequency analysis (RFA): Stability of individual implants was also measured with Osstell Mentor RFA device (Osstell, Integration Diagnostics) using the dedicated transducers (SmartPeg, Osstell) for the SPI 4.0 mm connection. All implants were measured twice (from mesio-distal and bucco-lingual directions and the two measurements were averaged) at implant placement, 1, 3 and 6 months after implant placement.
- Time needed to prepare the implant site: it was calculated in seconds by a dental assistant starting from the use of the first osteotomy instrument to the complete seating of the implant.
A blind outcome assessor (E.S.) assessed implant stability (RFA) and another blinded dentist (V.F.) measured marginal bone levels. Complications were handled and reported directly by the responsible clinician who was not blinded.
Sample size, randomisation and allocation concealment
A sample size was estimated in 47 implants, given an effect size d= 0.487065, 𝛂 err prob 0.05, and power (1-ß err prob=0.90). Effect size was determined based on a previous similar study reporting ISQ values of 75.7±5.2 in the piezosurgery and 73.3±4.6 in the conventional drilling group at 3 months (2). Due to the split-mouth design of the study, patients provided both test (piezosurgery) and control (conventional drilling) implants. In order to avoid underpowered results (<90%), unbalanced groups and to account for possible drop-outs, three implants were added, scoring a total sample size of 50 implants (25 patients).
One computer generated restricted randomisation lists was created. Only one investigator (K.S.), who was not involved in the selection and treatment of the patients, knew the random sequence and had access to the random list stored in a pass-word protected portable computer. The random codes were enclosed in sequentially numbered, identical, opaque, sealed envelopes. After flap elevation, the envelope corresponding to the patient recruitment number was opened, and implant site number 1 was allocated to the group determined by the content of the envelope, and other site received the alternative intervention. Therefore, treatment allocation was concealed to the investigators in charge of enrolling and treating the patients.
Statistical analysis
All data analysis was performed according to a pre-established analysis plan by a dentist (JB) with expertise in statistics who analysed the data without knowledge of the group codes. The implant sites were the statistical unit of the analyses. Differences between the groups in crown/implant failures and complications (dichotomous outcomes) were compared using a McNemar test. Between-group differences for continuous outcomes (mean marginal bone level and RFA) at different time points were estimated by paired t-test. Comparisons between the various follow-up endpoints and the baseline measurements were made by paired t-tests, to detect any changes in mean marginal bone level for each study group. Two-level (patient and implant) mixed effect models with patient as random effect for each time point after implant placement with baseline (implant placement) as a covariate were created to estimate between-group differences for mean marginal bone level and RFA changes from baseline. A further two-level (patient and implant) mixed effect model with patient as random effect was created to evaluate the soft tissue thickness as predictor of marginal bone level changes over time adjusted for baseline ISQ values. All statistical comparisons were conducted at the 0.05 level of significance.